Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03770455
Title Phase II Trial of Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Jodi Layton, MD

prostate adenocarcinoma


Avelumab + Enzalutamide

Abiraterone + Avelumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.